...
首页> 外文期刊>Expert opinion on therapeutic targets >Inhibition of the tonic contraction in the treatment of erectile dysfunction.
【24h】

Inhibition of the tonic contraction in the treatment of erectile dysfunction.

机译:在勃起功能障碍的治疗中抑制强直性收缩。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Erectile dysfunction (ED) reduces the quality of life. It is estimated that 52% of men have some degree of ED, which is associated with ageing. While it is clear that there are a variety of current treatment options for ED, each of these has drawbacks and contraindications. A better understanding of the physiological mechanisms involved in penile erection will provide new ways to treat ED. This review not only focuses on the vasoconstrictors and vasodilators that control the state of contraction and relaxation of the corpora cavernosa smooth muscle, but also presents a novel Ca(2+)-sensitising pathway that contributes to maintaining the penis in the non-erect state. Studies have shown that inhibition of the RhoA/Rho-kinase signalling pathway induces penile erection. Further understanding of this RhoA/Rho-kinase pathway may provide a novel alternative treatment for ED.
机译:勃起功能障碍(ED)会降低生活质量。据估计,有52%的男性患有一定程度的ED,这与衰老有关。显然,目前有多种治疗ED的方法,但每种方法都有缺点和禁忌症。对阴茎勃起涉及的生理机制的更好理解将为治疗ED提供新的方法。这篇综述不仅着重于控制海绵体平滑肌的收缩和松弛状态的血管收缩剂和血管舒张剂,而且还提出了一种新颖的Ca(2+)致敏途径,有助于将阴茎保持在非勃起状态。 。研究表明,抑制RhoA / Rho激酶信号传导途径可诱导阴茎勃起。对该RhoA / Rho激酶途径的进一步了解可能为ED提供一种新颖的替代治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号